LYV closed Tuesday's session at $157.26, barely changed on the day. The stock is up 1.6% on the week. But the real action is in what happened after hours — Q1 2026 results landed on May 5, and they told a split story: revenues beat estimates, but the bottom line missed by $1.50 per share.
The positioning coming into that print was already charged. Short interest has been building steadily since late March, climbing from roughly 18.4 million shares to a peak above 21.5 million in mid-April before easing slightly. At 9% of the free float, this is a meaningful short book — and it held its ground through the week, declining just 0.8% over five sessions. The message from the borrow market reinforces the same read: cost to borrow has come down sharply from a month ago (off around 28%) and now sits at a modest 0.47%, reflecting a well-supplied lending pool. Availability is around 264% of estimated short interest, meaning there is no shortage of shares to lend. This is not a squeeze setup. Shorts are comfortable, borrow is cheap, and the position has been building with patience rather than urgency.
Options traders told a different story heading into earnings. The put/call ratio has pulled back to 0.99 — nearly a full standard deviation below the 20-day average of 1.12 — suggesting the defensive tone that dominated April has eased. Through mid-April, the PCR was running above 1.3 on several sessions, touching 1.39 on April 15. That hedging posture has now unwound, with call activity picking up relative to puts in the days immediately around the print. The shift is notable: going into a quarter where the EPS miss was significant, options participants were actually less guarded than usual.
The Street reacted today with nuance rather than alarm. Guggenheim raised its target to $197 from $192 and kept its Buy rating intact, reading the revenue beat as the primary signal. Wells Fargo moved the other way on the target — trimming to $199 from $203 — while holding Overweight. Goldman Sachs also raised its target to $192 in March, and Citizens initiated at Market Outperform with a $190 target. The consensus mean sits at $184.52 against a close of $157.26, implying roughly 17% upside. The bull case rests on double-digit AOI growth through 2026, venue expansion, and Live Nation's structural dominance of the live events pipeline. The bear case is more textured: artist concentration risk, Ticketmaster's regulatory overhang, and the sheer operating leverage that turns a soft quarter into a large EPS miss. At 15.2x EV/EBITDA and a P/E north of 94x on trailing earnings, the stock demands execution. The EPS surprise factor score ranks in the 90th percentile historically — but Q1 demonstrated that streak is breakable.
CEO Michael Rapino has been a consistent seller. He offloaded shares in February, March, and April — most recently 24,904 shares at $163.66 on April 9, a transaction worth roughly $4.1 million. Across the 90-day window the insider register shows net selling above $15 million in value. None of this is unusual for a founder/CEO managing equity compensation, but the volume and frequency are worth noting alongside the short interest build. Liberty Media remains the anchor holder at nearly 30% of shares, while Vanguard, BlackRock, and State Street have all marginally added to positions in recent months.
The next session will be the first full trading day following the Q1 print. Analyst reactions are still arriving — the read on whether the revenue beat outweighs the EPS shortfall will start to crystallise in the price. The prior earnings print in February produced a 4.5% single-day gain. Whether the market extends the same patience this time, given a wider-than-expected loss, is the question the tape will answer.
See the live data behind this article on ORTEX.
Open LYV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
